ERBB2 and triple-negative breast carcinoma: Stevic et al. analyzed the presence of a panel of 45 exosomal miRNAs in plasma from 435 patients diagnosed with either HER2+ or triple-negative breast cancer and indeed confirmed that the exosomal miRNA content differed among the two breast cancer subtypes [108].